MEC Plus

RET, MET, and BRAF Mutant Lung Cancer Tumors
RET, MET, and BRAF Mutant Lung Cancer Tumors
Edgardo S. Santos Castillero, MD, FACP
Controversial Management in Breast Cancer
Controversial Management in Breast Cancer
Mohammad Jahanzeb, MD, FACP, FASCO
Breast Cancer Immunotherapy
Breast Cancer Immunotherapy
Mariana Chavez-MacGregor, MD
Challenges in End of Life Care
Challenges in End of Life Care
Amber Thomassen, MA, MSN, APRN-BC, AOCNP
Biosimilars as Front Line Options for Cancer Care
Biosimilars as Front Line Options for Cancer Care
Jorge J. García, PharmD, MS, MHA, MBA, FACHE
Other Oncogene-Driven Cancers
Other Oncogene-Driven Cancers
Collin Blakely, MD, PhD
Tumor Biology, Pathology, Novel Diagnostics
Tumor Biology, Pathology, Novel Diagnostics
Tianhong “Tina” Li, MD, PhD